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Introduction
Mammary tumors are among the most common tumors seen in female dogs. Canine mammary tumors are heterogeneous with a 
wide array of histologic lesions and clinical behaviors. Approximately 50% are benign and 50% are malignant, and many diagnoses 
are possible in one patient. Specific diagnosis can often be achieved with biopsy. The goal of this lecture is to familiarize clinicians 
with common and prognostically relevant tumor types to enhance interpretation of biopsy reports. This information can be used 
together with other clinical prognostic factors to predict patient outcome and to plan patient management and treatment.
Risk Factors
Age, breed, diet, and spay status are known to influence the risk of mammary tumor development. The risk is increased in 
older dogs, in small breed dogs, especially toy and miniature breeds, in obese dogs, and in intact females. Among age groups, 
malignant tumors are more common in dogs 9-13 years old, and benign tumors usually are more common in dogs 7-9 years old. 
Spaying has a protective effect, especially if performed at a young age.
Pathology Submissions
Cytology has poor sensitivity for differentiation between benign vs. malignant mammary tumors; however, it is a useful tool for 
diagnosis of non-mammary tumors (i.e. mast cell tumor) or for determining an epithelial origin. Biopsy is often needed for full 
characterization of mammary gland masses. Biopsy samples should be removed with at least a few millimeters of surrounding 
tissue so that all features can be evaluated histologically for malignancy. Specimens should be submitted to the laboratory with an 
adequate and relevant clinical history.
Histologic Classification
Histologic lesions range from benign hyperplasia to highly malignant cancers. Over 50 types of mammary tumors can occur in the 
mammary gland. Understanding the terminology and clinical significance of these tumors can be overwhelming. A basic concept 
in mammary tumor diagnosis is the division of simple, complex, and mixed tumors. Simple tumors are composed of epithelial 
cells only, complex tumors are composed of epithelial cells and myoepithelial cells, and mixed tumors have epithelial cells and/
or myoepithelial cells with the addition of mesenchymal tissue, usually cartilage and/or bone. Listed below are diagnoses that are 
either common or are associated with a worse prognosis (italics).
Common and Prognostically Significant Canine Mammary Tumors
*Inflammatory carcinoma is not a histologic subtype, but rather a clinical entity that can be associated with many malignant 
subtypes. It is caused by plugging of dermal lymphatic vessels with neoplastic emboli, which creates clinical signs that mimic 
inflammation.
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Carcinoma arising in a complex adenoma






Besides the noted malignant subtypes italicized above, other histologic prognostic factors include histologic grade and the 
presence of vascular invasion. Carcinomas are graded I-III with grade III tumors having the worst prognosis. The grade should be 
included on your pathology report. Poor prognostic clinical indicators include older age, large breed (though may be more related 
to reduced lifespan vs. small breeds), tumor size >3 cm, intact status, and increasing clinical stage. Staging is performed according 
to WHO guidelines for animals.
Summary
Canine mammary tumors are common and have highly variable appearances and clinical behaviors. Biopsy is a useful tool 
for diagnosing the specific tumor type and can provide insight on prognosis. This lecture has attempted to provide a basic 
understanding of common tumor types and has highlighted keywords to look for on your biopsy report that should alert you to 
a poor prognosis. The table below depicts a subjective emotional scale for the range of diagnoses you might see on your biopsy 
report.
Interpreting Your Histologic Diagnosis
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